Edition:
India

People: Prometic Life Sciences Inc (PLI.TO)

PLI.TO on Toronto Stock Exchange

0.73CAD
18 May 2018
Change (% chg)

$-0.01 (-1.35%)
Prev Close
$0.74
Open
$0.72
Day's High
$0.74
Day's Low
$0.72
Volume
208,170
Avg. Vol
1,115,690
52-wk High
$2.11
52-wk Low
$0.63

Moran, John 

Dr. John Moran, M.D., FRACP, FACP, FACPE is Chief Medical Officer, Director of ProMetic Life Sciences Inc., since March 1st, 2014. From 2010 until joining the Corporation, Dr. Moran was Vice President, Clinical Affairs - Home modalities at DaVita Healthcare Partners Inc. where he had the overall responsibility for quality of care and related business issues for over 20,000 home dialysis patients in over 1,000 care centers. Previously, Dr. Moran served for eight years as Senior Vice President, Clinical Affairs for Satellite Healthcare. Dr. Moran also served at Baxter Healthcare as Global Medical Director for the Renal Division for five years and for two years as Vice President for Clinical Development and Marketing. Dr. John Moran sits on the board of directors of Intelomed, Inc., a US private company.

Basic Compensation

Total Annual Compensation, CAD 597,481
Restricted Stock Award, CAD 100,081
Long-Term Incentive Plans, CAD --
All Other, CAD 140,835
Fiscal Year Total, CAD 838,397

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Simon Best

257,330

Pierre Laurin

2,208,730

Bruce Pritchard

1,334,840

John Moran

838,397

Bruce Wendel

108,706

Patrick Sartore

1,001,390
As Of  31 Dec 2016